ClinicalTrials.Veeva

Menu

Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study

B

Beijing Tsinghua Chang Gung Hospital

Status

Unknown

Conditions

Cholangiocarcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT04243057
RWS-BTCH-001

Details and patient eligibility

About

This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival

Secondary purpose:

  1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer
  2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer

Enrollment

5,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. above the age of 18 years old, male or female
  2. clinical diagnosis of patients with cholangiocarcinoma
  3. Child-Pugh classification of A, B
  4. Eastern Cooperative Oncology Group scoring system (ECOG) score of 0-2 points

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Xiaobin Feng, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems